<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05116839</url>
  </required_header>
  <id_info>
    <org_study_id>MS/19.03.556</org_study_id>
    <nct_id>NCT05116839</nct_id>
  </id_info>
  <brief_title>Pressure Support Ventilation Versus Continuous Positive Air Way Pressure (CPAP) Using I Gelin Adult Patients,</brief_title>
  <official_title>Pressure Support Ventilation Versus Continuous Positive Air Way Pressure (CPAP) Using I Gel Laryngeal Mask for Minor Surgery in Adult Patients, a Prospective cross_over Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mansoura University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mansoura University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Introduction of Supra glottic airway devices (SAD) has revolutionized the airway management.&#xD;
      The first successful supraglottic airway device, the Laryngeal Mask Airway(LMA).The various&#xD;
      other SADs include ProSeal LMA, Intubating LMA and i-gel to overcome the limitations of&#xD;
      classic Laryngeal Mask Airway( c-LMA) The risk of aspiration with c-LMA is reported tobe&#xD;
      around 9% , pleaseboth the c-LMA and PLMA have cuff related complications. High cuff pressure&#xD;
      in laryngeal mask airways can cause damage to the mucosae on periglottic and supraglottic&#xD;
      structures .&#xD;
&#xD;
      Therefore, to overcome the limitations of Pro Seal Laryngeal Mask Airway (PLMA )a new and&#xD;
      cheaper SAD called i-gel was developed. i-gel is a novel and innovative, latex free&#xD;
      supraglottic device, made up of medical grade thermoplastic elastomer, which is soft, gel&#xD;
      like, transparent The number of manipulations required are more in PLMA than i gel resulting&#xD;
      in hemodynamic changes .The i-gel is comparable to PLMA insuring the airway during controlled&#xD;
      ventilation. It is better than PLMA in terms of ease of insertion.&#xD;
&#xD;
      Spontaneous breathing is the most popular mode of ventilation with the laryngeal mask airway&#xD;
      (LMA), but it provides less effective gas exchange than does positive pressure ventilation&#xD;
      (PPV) . The patients receiving sevoflurane anesthesia with unassisted ventilation have a&#xD;
      reduced rib cage contribution to ventilation, decreased tidal volume, and respiratory rate .&#xD;
&#xD;
      Pressure support ventilation (PSV) is a ventilator mode that is initiated by the patient and&#xD;
      synchronized with the patient's respiratory effort. And may improve gaseous exchange in&#xD;
      patients. In the intensive care unit, it is often considered the preferred mode for weaning&#xD;
      mechanical ventilation .PSV provides more effective gas exchange than does unassisted&#xD;
      ventilation with CPAP during anesthesia with the LMA while preserving hemodynamic&#xD;
      homeostasis.&#xD;
&#xD;
      The use of PSV versus CPAP with the Pro Seal laryngeal mask airway in anesthetized pediatric&#xD;
      patients revealed that PSV improved gaseous exchange and reduced work of breathing during&#xD;
      general anesthesia PSV via Pro- Seal laryngeal mask airway improves gaseous exchange and&#xD;
      ventilation in pediatric patients under general anesthesia more than spontaneous ventilation&#xD;
      .&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients and Methods This prospective,cross over study will be conducted after obtaining&#xD;
      approval from the Institutional Review Board (IRB) of faculty of medicine Mansoura&#xD;
      University. A written informed consent will be obtained from all participants and the&#xD;
      duration of the study will be 2 - 6 months.&#xD;
&#xD;
      Participants:&#xD;
&#xD;
      38 Adult patients with American Society of Anesthesiologists (ASA) physical status (I - II&#xD;
      )of both sexes aged (18-65) years scheduled for minor surgery at Urology and Nephrology&#xD;
      centre (UNC) will be included in this study.&#xD;
&#xD;
      The Patients with a body mass index (BMI) &gt;40 or having obstructive air way disease will be&#xD;
      excluded.&#xD;
&#xD;
      All patients will be assessed on the day before surgery by detailed history thorough clinical&#xD;
      examination, and basal laboratory investigations [Complete blood count (CBC), Coagulation&#xD;
      profile (prothrombin time and INR), liver and renal function tests (liver enzymes, bilirubin,&#xD;
      albumin and s. creatinine], electrocardiograph (ECG) and echo cardiography when needed.&#xD;
&#xD;
      Anaesthesia Induction of anaesthesia with fentanyl 0.5Âµg/kg - propofol 1mg/kg prior for&#xD;
      insertion of device,primary success rate will be recorded.&#xD;
&#xD;
      Maintenance of anaesthesia by sevoflurane inhalation with minimal alveolar concentration&#xD;
      (MAC) 2%.&#xD;
&#xD;
      All patients will breath spontaneously from ventilators (Dragers - Primal - germany).&#xD;
&#xD;
      All patients will breath at the first 15 minutes with PSV:triggered by minute volume &lt;3&#xD;
      liter,with no frequency then the following 15 minutes ventilation will be changed to CPAP&#xD;
      mode at 10 cm H2o .&#xD;
&#xD;
      Monitoring: (basal&amp; every 3minutes)&#xD;
&#xD;
        1. Tidal volume (inspiratory &amp; expiratory).&#xD;
&#xD;
        2. End tidal co2.&#xD;
&#xD;
        3. Mean air way pressure.&#xD;
&#xD;
        4. Leakage %.&#xD;
&#xD;
        5. Respiratory rate .&#xD;
&#xD;
        6. Spo2.&#xD;
&#xD;
        7. Heart rate.&#xD;
&#xD;
        8. Blood pressure (mean arterial pressure). Adverse effects;Laryngeal spasm.Blood stained&#xD;
           device. .&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 31, 2019</start_date>
  <completion_date type="Anticipated">October 15, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 28, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>a prospective cross_over study</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Effective ventilation with PSV than does (CPAP) as regard Tidal volume</measure>
    <time_frame>30 minutes</time_frame>
    <description>Breathing of all patients at the first 15 minutes with PSV pressure support ventilation:triggered by minute volume &lt;3 liter,with no frequency then the following 15 minutes ventilation with CPAP .ventilation will be measured by Monitoring: (basal&amp; every 3minutes)Tidal volume (inspiratory &amp; expiratory).on ventilator monitor in mil/ kilogram</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Effective ventilation with PSV than does (CPAP) as regard End tidal co2. on ventilator</measure>
    <time_frame>30 minutes</time_frame>
    <description>Breathing of all patients at the first 15 minutes with PSV pressure support ventilation:triggered by minute volume &lt;3 liter,with no frequency then the following 15 minutes ventilation with CPAP.ventilation will be measured by Monitoring: (basal&amp; every 3minutes) End tidal co2. on ventilator ml/eq</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Effective ventilation with PSV than does CPAP as regard Mean air way pressure</measure>
    <time_frame>30 minutes</time_frame>
    <description>Breathing of all patients at the first 15 minutes with PSV pressure support ventilation:triggered by minute volume &lt;3 liter,with no frequency then the following 15 minutes ventilation with CPAP.ventilation will be measured by Monitoring: (basal&amp; every 3minutes) Mean air way pressure.on ventilator mmhg</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Effective ventilation with PSV than does (CPAP) as regard Leakage %</measure>
    <time_frame>30 minutes</time_frame>
    <description>Breathing of all patients at the first 15 minutes with PSVpressure support ventilation:triggered by minute volume &lt;3 liter,with no frequency then the following 15 minutes ventilation with CPAP.ventilation will be measured by Monitoring: (basal&amp; every 3minutes) Leakage % on ventilator monitor</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Effective ventilation with PSV than does CPAP as regard oxygen saturation.</measure>
    <time_frame>30 minutes</time_frame>
    <description>Breathing of all patients at the first 15 minutes with PSV pressure support ventilation:triggered by minute volume &lt;3 liter,with no frequency then the following 15 minutes ventilation with CPAP.ventilation will be measured by Monitoring: (basal&amp; every 3minutes) oxygen saturation.on monitoring in %</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Effective ventilation with PSV than does (CPAP) as regard respiratory rate</measure>
    <time_frame>30 minutes</time_frame>
    <description>Breathing of all patients at the first 15 minutes with PSV pressure support ventilation:triggered by minute volume &lt;3 liter,with no frequency then the following 15 minutes ventilation with CPAP .ventilation will be measured by Monitoring: (basal&amp; every 3minute)respiratory rate on monitor breath/ minute</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">38</enrollment>
  <condition>Ventilator Lung</condition>
  <arm_group>
    <arm_group_label>the first 15 minutes with PSV</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>All patients will breath at the first 15 minutes with PSV:triggered by minute volume &lt;3 Liter,with with no frequency .&#xD;
Monitoring: (basal&amp;every 3minutes)&#xD;
Tidal volume (inspiratory &amp; expiratory).&#xD;
End tidal co2.&#xD;
Mean air way pressure.&#xD;
Leakage %.&#xD;
Respiratory rate .&#xD;
Spo2.&#xD;
Heart rate.&#xD;
Blood pressure (mean arterial pressure</description>
  </arm_group>
  <arm_group>
    <arm_group_label>the following 15 minutes ventilation will be changed to CPAP mode</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>then the following 15 minutes ventilation will be changed to CPAP mode at 10 cm H2o .&#xD;
Monitoring: (basal&amp;every 3minutes)&#xD;
Tidal volume (inspiratory &amp; expiratory).&#xD;
End tidal co2.&#xD;
Mean air way pressure.&#xD;
Leakage %.&#xD;
Respiratory rate .&#xD;
Spo2.&#xD;
Heart rate.&#xD;
Blood pressure (mean arterial pressure).</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>the first 15 minutes with pressure support ventilation</intervention_name>
    <description>PSV pressure support ventilation:triggered by minute volume &lt; 3 Liter ,with no frequency</description>
    <arm_group_label>the first 15 minutes with PSV</arm_group_label>
    <other_name>lung mechanical ventilatory mode on mechanical ventilator</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>the following 15 minutes ventilation will be changed to continous positive air way pressureCPAP mode</intervention_name>
    <description>continous positive air way pressure CPAP mode at 10 cm H2o .</description>
    <arm_group_label>the following 15 minutes ventilation will be changed to CPAP mode</arm_group_label>
    <other_name>lung mechanical ventilatory mode on mechanical ventilator</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>i gel air way</intervention_name>
    <description>supraglottic air way device</description>
    <arm_group_label>the first 15 minutes with PSV</arm_group_label>
    <arm_group_label>the following 15 minutes ventilation will be changed to CPAP mode</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult patients with (ASA) physical status I - II years scheduled for minor surgery at&#xD;
             Urology and Nephrology centre (UNC) will be included in this study.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  The Patients with a body mass index (BMI) &gt;40 or having obstructive air way disease&#xD;
             will be excluded.â¢&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Golnar Se Hammouda, M.D</last_name>
    <role>Study Chair</role>
    <affiliation>Professor of Anesthesia Intensive Care Faculty of Medicine - Mansoura University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hanaa Ma El-Bendary, M.D</last_name>
    <role>Study Director</role>
    <affiliation>Assistant Professor of Anesthesia Intensive Care Faculty of Medicine - Mansoura University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Marwa Ib Abdo, M.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Lecturer of Anesthesia Intensive Care Faculty of Medicine - Mansoura University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Bahaa Mo Ezz, MBBCh</last_name>
    <role>Principal Investigator</role>
    <affiliation>Resident of Anesthesia Intensive Care Mansoura University Hospitals</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Marwa Ib Abdo, M.D</last_name>
    <phone>01002477789</phone>
    <email>marwaibr79@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Marwa Ib Abdo, M.D</last_name>
    <phone>01556660553</phone>
    <email>marwaibr792000@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Marwa Ibrahim Mohamed abdo</name>
      <address>
        <city>Mansoura</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marwa Ib Abdo, M.D</last_name>
      <phone>01002477789</phone>
      <email>marwaibr79@yahoo.com</email>
    </contact>
    <contact_backup>
      <last_name>Marwa Abdo, M.D</last_name>
      <phone>01556660553</phone>
      <email>marwaibr792000@gmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <reference>
    <citation>Barker P, Langton JA, Murphy PJ, Rowbotham DJ. Regurgitation of gastric contents during general anaesthesia using the laryngeal mask airway. Br J Anaesth. 1992 Sep;69(3):314-5.</citation>
    <PMID>1389850</PMID>
  </reference>
  <reference>
    <citation>Wong JG, Heaney M, Chambers NA, Erb TO, von Ungern-Sternberg BS. Impact of laryngeal mask airway cuff pressures on the incidence of sore throat in children. Paediatr Anaesth. 2009 May;19(5):464-9. doi: 10.1111/j.1460-9592.2009.02968.x. Epub 2009 Mar 5.</citation>
    <PMID>19281479</PMID>
  </reference>
  <reference>
    <citation>Levitan RM, Kinkle WC. Initial anatomic investigations of the I-gel airway: a novel supraglottic airway without inflatable cuff. Anaesthesia. 2005 Oct;60(10):1022-6.</citation>
    <PMID>16179048</PMID>
  </reference>
  <reference>
    <citation>Chauhan G, Nayar P, Seth A, Gupta K, Panwar M, Agrawal N. Comparison of clinical performance of the I-gel with LMA proseal. J Anaesthesiol Clin Pharmacol. 2013 Jan;29(1):56-60. doi: 10.4103/0970-9185.105798.</citation>
    <PMID>23493414</PMID>
  </reference>
  <reference>
    <citation>Verghese C, Brimacombe JR. Survey of laryngeal mask airway usage in 11,910 patients: safety and efficacy for conventional and nonconventional usage. Anesth Analg. 1996 Jan;82(1):129-33.</citation>
    <PMID>8712387</PMID>
  </reference>
  <reference>
    <citation>Keller C, Sparr HJ, Luger TJ, Brimacombe J. Patient outcomes with positive pressure versus spontaneous ventilation in non-paralysed adults with the laryngeal mask. Can J Anaesth. 1998 Jun;45(6):564-7.</citation>
    <PMID>9669012</PMID>
  </reference>
  <reference>
    <citation>Tokioka H, Nagano O, Ohta Y, Hirakawa M. Pressure support ventilation augments spontaneous breathing with improved thoracoabdominal synchrony in neonates with congenital heart disease. Anesth Analg. 1997 Oct;85(4):789-93.</citation>
    <PMID>9322456</PMID>
  </reference>
  <reference>
    <citation>Farias JA, Frutos F, Esteban A, Flores JC, Retta A, Baltodano A, AlÃ­a I, Hatzis T, Olazarri F, Petros A, Johnson M. What is the daily practice of mechanical ventilation in pediatric intensive care units? A multicenter study. Intensive Care Med. 2004 May;30(5):918-25. Epub 2004 Mar 17.</citation>
    <PMID>15029473</PMID>
  </reference>
  <reference>
    <citation>Brimacombe J, Keller C, HÃ¶rmann C. Pressure support ventilation versus continuous positive airway pressure with the laryngeal mask airway: a randomized crossover study of anesthetized adult patients. Anesthesiology. 2000 Jun;92(6):1621-3.</citation>
    <PMID>10839911</PMID>
  </reference>
  <reference>
    <citation>von Goedecke A, Brimacombe J, HÃ¶rmann C, Jeske H-, Kleinsasser A, Keller C. Pressure support ventilation versus continuous positive airway pressure ventilation with the ProSeal laryngeal mask airway: a randomized crossover study of anesthetized pediatric patients. Anesth Analg. 2005 Feb;100(2):357-360. doi: 10.1213/01.ANE.0000143563.39519.FD.</citation>
    <PMID>15673856</PMID>
  </reference>
  <reference>
    <citation>Lim B, Pawar D, Ng O. Pressure support ventilation vs spontaneous ventilation via ProSealâ¢ laryngeal mask airway in pediatric patients undergoing ambulatory surgery: a randomized controlled trial. Paediatr Anaesth. 2012 Apr;22(4):360-4. doi: 10.1111/j.1460-9592.2012.03819.x.</citation>
    <PMID>22380745</PMID>
  </reference>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>August 20, 2021</study_first_submitted>
  <study_first_submitted_qc>October 31, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 11, 2021</study_first_posted>
  <last_update_submitted>November 16, 2021</last_update_submitted>
  <last_update_submitted_qc>November 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mansoura University</investigator_affiliation>
    <investigator_full_name>Marwa Ibrahim Mohamed Abdo,MD</investigator_full_name>
    <investigator_title>Lecturer of Anesthesia and Surgical Intensive Care-Faculty of Medicine - Mansoura University</investigator_title>
  </responsible_party>
  <keyword>Pressure support ventilation (CPAP) I gel</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

